About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Dok2tm1Yyam
targeted mutation 1, Yuji Yamanashi
MGI:3527416
Summary 5 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cx1
Dok1tm1Yyam/Dok1tm1Yyam
Dok2tm1Yyam/Dok2tm1Yyam
B6.129-Dok1tm1Yyam Dok2tm1Yyam MGI:3574536
cx2
Dok1tm1Yyam/Dok1tm1Yyam
Dok2tm1Yyam/Dok2tm1Yyam
involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 MGI:4829895
cx3
Dok1tm1Yyam/Dok1tm1Yyam
Dok2tm1Yyam/Dok2tm1Yyam
Dok3tm1Brs/Dok3tm1Brs
involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 MGI:4829896
cx4
Dok1tm1Yyam/Dok1tm1Yyam
Dok2tm1Yyam/Dok2tm1Yyam
Tg(Tec-BCR/ABL1)5Hhi/0
involves: C57BL/6 MGI:3574538
cx5
Dok2tm1Yyam/Dok2tm1Yyam
Tg(Tec-BCR/ABL1)5Hhi/0
involves: C57BL/6 MGI:3574539


Genotype
MGI:3574536
cx1
Allelic
Composition
Dok1tm1Yyam/Dok1tm1Yyam
Dok2tm1Yyam/Dok2tm1Yyam
Genetic
Background
B6.129-Dok1tm1Yyam Dok2tm1Yyam
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Dok1tm1Yyam mutation (0 available); any Dok1 mutation (19 available)
Dok2tm1Yyam mutation (0 available); any Dok2 mutation (16 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• double homozygotes develop myeloproliferative disease by about 1 year of age with atypical myeloid cells resembling myelomonocytic cells
• cellular infiltrations of granulocytes and lymphocytes are seen in several tissues
• about half of the double homozygotes with myeloproliferative disease develop histiocytic sarcoma of macrophage origin

hematopoietic system
• at about 1 year of age double homozygotes have enlarged spleens where immature and mature granulocytes/monocytes, erythroblasts, and atypical myeloid cells accumulate
• bone marrow and spleen have an increased ratio of immature granulocytic and/or monocytic precursors
• hyperplasia of myeloid precursors
• hyperplasia of megakaryocytes
• hyperplasia of erythroblasts
• leukocyte numbers in the peripheral blood are significantly higher
• at 8 weeks of age bone marrow derived mast cells display increased proliferation in response to cytokines and attenuated apoptosis when deprived of cytokines

immune system
• at about 1 year of age double homozygotes have enlarged spleens where immature and mature granulocytes/monocytes, erythroblasts, and atypical myeloid cells accumulate
• bone marrow and spleen have an increased ratio of immature granulocytic and/or monocytic precursors
• hyperplasia of myeloid precursors
• leukocyte numbers in the peripheral blood are significantly higher
• at 8 weeks of age bone marrow derived mast cells display increased proliferation in response to cytokines and attenuated apoptosis when deprived of cytokines

growth/size/body
• at about 1 year of age double homozygotes have enlarged spleens where immature and mature granulocytes/monocytes, erythroblasts, and atypical myeloid cells accumulate

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
chronic myeloid leukemia DOID:8552 OMIM:608232
J:95335




Genotype
MGI:4829895
cx2
Allelic
Composition
Dok1tm1Yyam/Dok1tm1Yyam
Dok2tm1Yyam/Dok2tm1Yyam
Genetic
Background
involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Dok1tm1Yyam mutation (0 available); any Dok1 mutation (19 available)
Dok2tm1Yyam mutation (0 available); any Dok2 mutation (16 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• bone marrow-derived macrophages at 10-12 weeks of age stimulated with M-CSF and GM-CSF, show an increased proliferative response compared to wild-type

hematopoietic system
• bone marrow-derived macrophages at 10-12 weeks of age stimulated with M-CSF and GM-CSF, show an increased proliferative response compared to wild-type




Genotype
MGI:4829896
cx3
Allelic
Composition
Dok1tm1Yyam/Dok1tm1Yyam
Dok2tm1Yyam/Dok2tm1Yyam
Dok3tm1Brs/Dok3tm1Brs
Genetic
Background
involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Dok1tm1Yyam mutation (0 available); any Dok1 mutation (19 available)
Dok2tm1Yyam mutation (0 available); any Dok2 mutation (16 available)
Dok3tm1Brs mutation (0 available); any Dok3 mutation (18 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• nearly half (15 of 33) of the mice died between 14?51 weeks after birth

neoplasm
• a markedly high incidence (24 of 41) of large cell tumors at 65 weeks of age
• abnormal proliferative cells with histiocytic morphology and cell surface markers in the bone marrow, spleen, and/or liver
• the histiocytic sarcoma is highly invasive and transplantable

hematopoietic system
• abnormal Mac-2-positive macrophages in the lung
• bone marrow-derived macrophages at 10-12 weeks of age stimulated with M-CSF and GM-CSF, show an increased proliferative response

immune system
• abnormal Mac-2-positive macrophages in the lung
• bone marrow-derived macrophages at 10-12 weeks of age stimulated with M-CSF and GM-CSF, show an increased proliferative response




Genotype
MGI:3574538
cx4
Allelic
Composition
Dok1tm1Yyam/Dok1tm1Yyam
Dok2tm1Yyam/Dok2tm1Yyam
Tg(Tec-BCR/ABL1)5Hhi/0
Genetic
Background
involves: C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Dok1tm1Yyam mutation (0 available); any Dok1 mutation (19 available)
Dok2tm1Yyam mutation (0 available); any Dok2 mutation (16 available)
Tg(Tec-BCR/ABL1)5Hhi mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• mutants begin to die at 4-5 months of age with few surviving beyond 6-9 months of age unlike mice hemizygous for Tg(BCR/ABL1)5Hhi which survive until 1 year of age

neoplasm
• severe blastic transformation is seen at 4-5 months of age with tumor cells composed of double positive immature T lymphoblasts

immune system
• enlarged thymus with massive infiltration of lymphoblasts seen at 4-5 months of age
• enlarged lymph node with massive infiltration of lymphoblasts seen at 4-5 months of age

hematopoietic system
• enlarged thymus with massive infiltration of lymphoblasts seen at 4-5 months of age

endocrine/exocrine glands
• enlarged thymus with massive infiltration of lymphoblasts seen at 4-5 months of age

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
chronic myeloid leukemia DOID:8552 OMIM:608232
J:95335




Genotype
MGI:3574539
cx5
Allelic
Composition
Dok2tm1Yyam/Dok2tm1Yyam
Tg(Tec-BCR/ABL1)5Hhi/0
Genetic
Background
involves: C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Dok2tm1Yyam mutation (0 available); any Dok2 mutation (16 available)
Tg(Tec-BCR/ABL1)5Hhi mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• mutants begin to die at 4-5 months of age with few surviving beyond 6-9 months of age unlike mice hemizygous for Tg(BCR/ABL1)5Hhi which survive until 1 year of age

neoplasm
• severe blastic transformation is seen at 4-5 months of age with tumor cells composed of double positive immature T lymphoblasts

immune system
• enlarged thymus with massive infiltration of lymphoblasts seen at 4-5 months of age
• enlarged lymph node with massive infiltration of lymphoblasts seen at 4-5 months of age

hematopoietic system
• enlarged thymus with massive infiltration of lymphoblasts seen at 4-5 months of age

endocrine/exocrine glands
• enlarged thymus with massive infiltration of lymphoblasts seen at 4-5 months of age

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
chronic myeloid leukemia DOID:8552 OMIM:608232
J:95335





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory